Bilimsel Makale Arama | NeuralCipher AI

Kaynak kaydı

Severe Parkinson's Disease Linked to SNCA Locus Triplication Is Associated with Expression Changes in Platelets: A Case Report.

Jiménez-Román S, Adamuz D, Mena J, Tuset A, Mallo M, Menendez A, Samaniego D, Ispierto L, Vilas D, Pastor P, Beyer K.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70529PMID: 42876074

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

Tay YW, Lee AL, Schee JP, Lin CH, Tan EK, Shin JH, Chen PS, Fan SP, Li CH, Ng EYL, Kim HJ, Jeon B, Koks S, Vu HTT, Mok KY, Lim YT, Kamaruddin MS, Toh TS, Ding HX, Anuar ANK, Ramli N, Keller Sarmiento IJ, Periñan MT, Fang ZH, Lange LM, Kumar KR, Bardien S, Trinh J, Valente EM, SG10K_Health Consortium, the Global Parkinson's Genetics Program (GP2), Heutink P, Lohmann K, Klein C, Mencacci NE, Lim SY, Ahmad-Annuar A, Tan AH.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70530PMID: 42876073

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.

Pérez-Pérez J, Olmedo-Saura G, Puig Davi A, Pérez González R, Pegueroles J, Horta-Barba A, Vázquez Oliver A, Rivas Asensio E, Alcolea D, Fortea J, Guasch-Jiménez M, Xuclà Ferrarons T, Sampedro Santaló F, Bojtos L, López-Lombardía Ó, Aracil-Bolaños I, Pascual-Sedano B, Franch Martí C, Pérez Carasol L, Rubio Romera M, Ji Y, Gironell A, Campolongo A, Martínez-Fernández R, Lleó A, Pagonabarraga J, Martínez-Horta S, Kulisevsky J, BCN‐HD Working Group;, HDClarity investigators.

Mov Disord · 2026-10-14

DOI: 10.1002/mds.70550PMID: 42876089

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Elevated erythrocyte membrane pS42-α-synuclein in Parkinson's disease and its changes following plasma cross-incubation.

Zhang Z, Xu J, Huang J, Wang S, Jian M, Feng C, Cui X, Zhou X, Yan J, Xu Y.

Parkinsonism Relat Disord · 2026-10-14

DOI: 10.1016/j.parkreldis.2026.109020PMID: 42887361

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.

Otmanine K, Hammoudi M, Bendriss H, Feraoun B, Mekhane S, Gherioune N, Benmehache C, Kerrouzi I, Ayadi K, El Miloudi K, Benghalia MA, Otmanine MK, Hentabli M.

Bioorg Chem · 2026-10-14

DOI: 10.1016/j.bioorg.2026.110653PMID: 42893649

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.

Chaudhary S, Dhankhar S, Saini M, Singh TG, Chauhan S, Kumar V.

CNS Neurol Disord Drug Targets · 2026-10-14

DOI: 10.2174/0118715273491538261009064612PMID: 42895147

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A novel UPLC-ECD method for simultaneous quantification of levodopa, benserazide, and their major metabolites in human plasma and cerebrospinal fluid.

Lu S, Qiu Y, Ma S, Huang Q, Li M, Wu L.

J Pharm Biomed Anal · 2026-10-14

DOI: 10.1016/j.jpba.2026.117770PMID: 42906213

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Quantitative Evaluation of Respiratory Dysfunction and Its Relationships With Parkinson's Disease Symptoms.

Pilipovich AA, Vorob'eva OV, Makarov SA, Shindryaeva NN.

Parkinsons Dis · 2026-10-13

DOI: 10.1155/padi/9026870PMID: 42871674

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

A clinically interpretable model for Parkinson's disease: insights from complementary MRI modalities.

Zheng Q, Wen J, Yuan W, Qin J, Duanmu X, Wu H, Zhu Z, Guo T, Wu C, Zhou C, Wu J, Chen J, Fang Y, Zhu B, Yan Y, Tian J, Zhang B, He H, Zhang M, Guan X, Xu X.

Brain Commun · 2026-10-13

DOI: 10.1093/braincomms/fcag383PMID: 42909910

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Changes in sleep disturbances and quality of life associated with Istradefylline in patients with Parkinson's disease: an exploratory polysomnographic study.

Miyaue N, Yabe H.

Clin Park Relat Disord · 2026-10-13

DOI: 10.1016/j.prdoa.2026.100512PMID: 42921407

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Adverse drug reactions associated with psychotropic medications combined with versus without lithium: A case/control pharmacovigilance analysis.

Greil W, de Bardeci M, Nievergelt N, Erfurth A, Hasler G, Cattapan K, Bleich S, Toto S, Seifert J, Grohmann R, Schoretsanitis G.

J Psychopharmacol · 2026-10-13

DOI: 10.1177/02698811261488471PMID: 42865315

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer's Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain.

Cushing BJ, Shahidehpour RK, Abner EL, Jicha GA, Neltner JM, Breig MK, Teodorescu KL, Neltner AM, Coskun EP, Kovacs GG, Nelson PT.

Acta Neuropathol · 2026-10-13

DOI: 10.1007/s00401-026-03100-8PMID: 42867534

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

100.694 makale bulundu

Severe Parkinson's Disease Linked to SNCA Locus Triplication Is Associated with Expression Changes in Platelets: A Case Report.

GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations.

Neurofilament Light Chain and Mutant Huntingtin Across Huntington's Disease Integrated Staging System Stages in Huntington Disease: A Cross-Sectional Multimodal Analysis.

Elevated erythrocyte membrane pS42-α-synuclein in Parkinson's disease and its changes following plasma cross-incubation.

Integrating graph attention networks and deep learning with multi-stage computational screening: Bisdemethoxycurcumin as a potent A₂A receptor inhibitor for Parkinson's disease.

Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.

A novel UPLC-ECD method for simultaneous quantification of levodopa, benserazide, and their major metabolites in human plasma and cerebrospinal fluid.

Quantitative Evaluation of Respiratory Dysfunction and Its Relationships With Parkinson's Disease Symptoms.

A clinically interpretable model for Parkinson's disease: insights from complementary MRI modalities.

Changes in sleep disturbances and quality of life associated with Istradefylline in patients with Parkinson's disease: an exploratory polysomnographic study.

Adverse drug reactions associated with psychotropic medications combined with versus without lithium: A case/control pharmacovigilance analysis.

Incident versus prevalent progressive supranuclear palsy: analyses of U.S. Alzheimer's Disease Research Centers data indicate clinical and neuropathological features of a relatively common and underrecognized tauopathy in the aging brain.

Filtreler